openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX)

10-21-2019 11:21 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares.

An investigation on behalf of current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Heron Therapeutics, Inc..

Investors who are current long term investors in Heron Therapeutics, Inc. (NASDAQ: HRTX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: HRTX stocks follows a lawsuit filed against Heron Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: HRTX stocks, concerns whether certain Heron Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011, that the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011, and that as a result, Heron’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) here

News-ID: 1853738 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Heron

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2022 - Heron Ther …
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing, and marketing strategies. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers, and acquisitions are mentioned in the report. The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
Netupitant-Palonosetron FDC Market In Depth Analysis 2021 To 2071Eisai Pharmaceu …
 The research study presented here is an intelligent take on the global Netupitant-Palonosetron FDC Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porter’s Five Forces analysis, and PESTLE analysis of the global Netupitant-Palonosetron FDC market. In addition,
Aprepitant Market 2027: Industry Growth, Competitive Analysis & Future Prospects …
This report properly guides new entrants as well as established players to make a difference in the global Aprepitant market. It is just the right resource for any player looking to plan new strategies. LOS ANGELES, United States: The report is an all-inclusive research study of the global Aprepitant market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive
Polymers Drug Delivery Market May See a Big Move: Sanofi, Heron, Alkermes, Eisai
Latest Research Study on Global Polymers Drug Delivery Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Polymers Drug Delivery Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Polymers Drug Delivery. This Report
Global Netupitant-Palonosetron FDC Market 2017 - Tesaro, Helsinn Group, Acacia P …
Qyresearchreports include new market research report Global Netupitant-Palonosetron FDC Sales Market Report 2017 to its huge collection of research reports. This report on the Netupitant-Palonosetron FDC has been compiled after conducting extensive primary and secondary research through seasoned hands. Primary research has covered a bulk of the efforts taken to prepare the report, including key discussions with several important opinion leaders and industry experts and significant data collected with the help
Global Resistance Welding Machine Market 2017 - Illinois Tool Works, CEA, Heron, …
Global Resistance Welding Machine Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Resistance Welding Machine piece of the overall industry and Growth patterns, concentrating on driving Resistance Welding Machine industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2022. The major regions present in the continents like United States, Germany, Japan and China and their contribution to global Resistance